🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fabulous session on components of an MDT in #Diabetes #DUKPC Diabetes Specialist Nurse Primary Care Nurse Pharmacist Dietitian Psychologist GP Lived experience Thanks Diabetes UK for opportunity to discuss topic around scope, expertise & care Hot topic - no? NHS England Workforce, Training and Education

Great fun when you are presenting with your buddies Hannah Beba Ahmed Iqbal 🇬🇧 showing colloborative working Diabetes UK pharmacy PIN #dukpc2025

📢 MASLD: The ‘Elephant in the Room’ of #CardioRenalMetabolic Health 🔹 Global crisis: 1 in 3 adults affected, 65% in #T2D 🔸 Liver fibrosis = key predictor of mortality & extrahepatic risks (#CVD, #CKD, HCC) 🔹 No approved Rx (except resmetirom) – 🎯 lifestyle, weight loss &

Thank you to Alia Gilani for putting together a thought provoking session on a topic so important for our healthcare systems !

Great session at #dukpc reflecting on the importance of the diabetes MDT: It’s when we work together that we ensure the best outcomes #diabetes #teamwork Thank you Sarah Alicea

📢 GLP-1RAs & blood cancer risk: Encouraging signal in new cohort study 🔹 #T2D patients on GLP-1RA ⤵️ risk vs. insulin across multiple hematological cancers (HR 0.46) 🔸 ⤵️ risk of MDS, MPN, leukaemia, lymphoma & myeloma 🔹 No benefit vs. metformin—likely due to metformin’s

Albuminuria: The CKM biomarker we’re overlooking❗️ 💡The best risk stratifying biomarker 🔹 Even UACR <3.4 mg/mmol = ⤴️ #CVD, #CKD & mortality risk 🔸 Signals early endothelial dysfunction across HTN, #T2D, #HF & #MASLD 🔹 Yet 💧screening rates low, esp. in primary care 🔸

🚨CagriSema hits 15.7% weight loss in #T2D + obesity — REDEFINE 2 🔹 Dual amylin + GLP-1RA combo shows ⤴️ efficacy vs. placebo (mean loss: 15.7%) 🔸 89.7% achieved ≥5% weight loss over 68wks 🔹 Impressive, given mix of #T2D & obesity—often harder to treat 🔸 May challenge

Quality in Care (QiC) Diabetes 2025 is open for entry! Now in its 15th year, QiC Diabetes recognises, rewards and shares innovative practice. Enter now: qicdiabetes.awardsplatform.com For further information go to: qualityincare.org/diabetes/welco… #qicdiabetes Sanofi #diabetes

*NEWS* Highlighting this on 2 counts to the world of #Diabetes 1. Continued outstanding work from DSNforumUK on #Technology 2. An ask to follow John Pemberton who is doing outstanding work in this field (& wider) - welcome to X Use/ RT/ Cascade as needed Shivani Misra

🚨Orforglipron ACHIEVE-1 topline—and didn’t it just!🚨 🔹 First oral small-molecule GLP-1RA to succeed in a Phase 3 trial 🔸 ⤵️ HbA1c by up to 1.6% | ⤵️ weight by 7.9% at 40 weeks 🔹 65% hit ADA target HbA1c ≤6.5% 🔸 No liver signal, safety similar to injectables 👉

Sobering reading in the latest Int. Diabetes Fed. Diabetes Atlas: diabetesatlas.org The PCDO Society is at the forefront in delivering the best outcomes for our patients - looking to collaborate with like-minded organisations! niti pall

🔥My latest Guidelines in Practice from Medscape article is live 💡Key learning points for primary care from NICE Adrenal Insufficiency: Identification & Management guideline 🎯When to suspect adrenal insufficiency and physiological equivalent doses of glucocorticoids Link in comments 👇🏾

💊 Metformin for knees ⁉️New RCT suggests it helps 🔹 6-month RCT: metformin ⤵️ knee pain (–11.4mm VAS vs placebo; P = .01) 🔸 Also ⤵️ stiffness & ⤴️ function (WOMAC scores) 🔹 GI AEs mild, no serious events 🔸 Small study (n=107) but supports anti-inflammatory role in OA 👉

Our team are out at this year's #ECO2025 looking forward to learning about the latest innovations and advances in obesity care. @nicmilne @hannahbeba Clare Hambling

Absolutely incredible to be in person at #ECO25 to see SURMOUNT 5 presented PCDO Society Nicola Milne RN QN UKCPA Diabetes & Endocrinology Committee West Yorkshire Health and Care Partnership

Hear from Hannah Beba, live from ECO2025, who has just attended the session on SURMOUNT-5 - Tirzepatide vs Semaglutide.

Latest from ECO 2025 - tirzepatide shows greater effects on weight loss than semaglutide in people with obesity and without T2DM. Pam Brown reviews the implications for our practice: eu1.hubs.ly/H0j-_7H0

One of Heather Bell's standout messages from #ECO2025 is the importance of women's health in the field of obesity management. Watch the video to find out more!

Nicola Milne RN QN checking in from #ECO2025 -- "umbrella holistic care" surely a term we will be hearing more of! Hannah Beba Prof Kamlesh Khunti Clare Hambling